Synergy Pharmaceuticals (SGYP) Underwriters Execrcise Over-Allotment in 10M Offering

June 6, 2012 12:55 PM EDT
Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) announced the exercise of the remainder of the over-allotment option granted to the underwriters with respect to the purchase of 750,000 shares of common stock at a public offering price of $4.50 per share, in connection with its previously announced underwritten public offering of 10,000,000 shares of common stock, bringing total gross proceeds from the offering to $51,750,000.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Equity Offerings

Add Your Comment